A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

614

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2015

Study Completion Date

November 30, 2016

Conditions
Breast Cancer
Interventions
DRUG

Doxorubicin

Doxorubicin 60 mg/m2

DRUG

Cyclophosphamide

Cyclophosphamide 600 mg/m2

DRUG

Ixabepilone (Ixempra)

Ixabepilone 40 mg/m2

DRUG

Paclitaxel (Taxol)

Paclitaxel 80 mg/m2

Trial Locations (70)

15213

University of Pittsburgh Medical Center, Pittsburgh

18960

Bux-Mont Oncology, Fox Chase Cancer Center, Rockledge

20817

Center for Cancer and Blood Disorders, Bethesda

21237

Weinberg Cancer Institute at Franklin Square, Baltimore

23235

Virginia Cancer Institute, Richmond

23601

Peninsula Cancer Institute, Newport News

27215

Alamance Regional Medical Center, Burlington

29210

South Carolina Oncology Associates, PA, Columbia

29303

Spartanburg Regional Medical Center, Spartanburg

29425

Medical University of South Carolina, Charleston

29464

Lowcountry Hematology Oncology, Mt. Pleasant

29572

Coastal Cancer Center, Myrtle Beach

30045

Suburban Hem Onc, Lawrenceville

30309

Piedmont Healthcare, Atlanta

30322

Emory/Winship Cancer Institute, Atlanta

30501

Northeast Georgia Medical Center, Gainesville

30901

Augusta Oncology Associates, Augusta

Medical Oncology Associates of Augusta, Augusta

30912

Medical College of Georgia Cancer Specialists, Augusta

32256

Integrated Community Oncology Network, Jacksonville

32796

Space Coast Medical Associates, Titusville

33021

Memorial Regional Cancer Center, Hollywood

33180

Aventura Medical Center, Aventura

33308

Holy Cross Hospital, Fort Lauderdale

33328

Florida Cancer Care, Davie

33428

Lynn Cancer Institute, Boca Raton

33805

Watson Clinic Center for Cancer Care and Research, Lakeland

33901

Florida Cancer Specialists, Fort Myers

35801

Cancer Center of Huntsville, Huntsville

35805

Clearview Cancer Institute, Huntsville

36207

Northeast Alabama Regional Medical Center, Anniston

36604

University of Southern Alabama, Mobile

37023

Tennessee Oncology, PLLC, Nashville

37404

Associates in Hematology Oncology, Chattanooga

Chattanooga Oncology Hematology Associates, Chattanooga

38017

Family Cancer Center, Collierville

40207

Consultants in Blood Disorders and Cancer, Louisville

43219

Mid Ohio Oncology/Hematology, Inc./ The Mark H. Zangmeister Center, Columbus

43560

Hickman Cancer Center (Flower Hospital), Sylvania

44035

Hematology/Oncology Inc, Elyria

45242

Oncology Hematology Care, Cincinnati

46260

Hematology Oncology of Indiana, Indianapolis

47714

Oncology Hematology Associates of SW Indiana, Evansville

47802

Providence Medical Group, Terre Haute

49503

Grand Rapids Clinical Oncology Program, Grand Rapids

55436

Fairview Medical Oncology Clinic, Edina

60076

Hematology Oncology of the North Shore, Skokie

61761

Mid-Illinois Hematology & Oncology, Normal

63017

St. Louis Cancer Care, Chesterfield

64132

Research Medical Center, Kansas City

65804

St. John's Clinic, Springfield

66210

Kansas City Cancer Centers, Overland Park

66606

Cotton O'Neil Cancer Center, Topeka

68114

Methodist Cancer Center, Omaha

70806

Baton Rouge General Medical Center, Baton Rouge

72401

Northeast Arkansas Clinic, Jonesboro

76104

Center for Cancer and Blood Disorders, Fort Worth

77030

Medical Oncology Methodist Hospital, Houston

78258

South Texas Oncology and Hematology, San Antonio

78463

Coastal Bend Cancer Center, Corpus Christi

87109

New Mexico Oncology Hematology Consultants, Albuquerque

91750

Wilshire Oncology Medical Group, La Verne

91767

New Hope Cancer and Research Institute, Pomona

06360

Eastern Connecticut Hematology Oncology, Norwich

04101

Mercy Hospital, Portland

01608

Fallon Clinic, Worcester

07834

St. Clare's Hospital Oncology and Hematology, Denville

07960

Hematology Oncology Associates of Northern NJ, Morristown

08360

Southern Oncology and Hematology, Vineland

Unknown

San Juan Hospital, San Juan

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER

NCT00789581 - A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer | Biotech Hunter | Biotech Hunter